Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes

OBJECTIVE—β-Cell function in type 1 diabetes clinical trials is commonly measured by C-peptide response to a secretagogue in either a mixed-meal tolerance test (MMTT) or a glucagon stimulation test (GST). The Type 1 Diabetes TrialNet Research Group and the European C-peptide Trial (ECPT) Study Group...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenbaum, Carla J., Mandrup-Poulsen, Thomas, McGee, Paula Friedenberg, Battelino, Tadej, Haastert, Burkhard, Ludvigsson, Johnny, Pozzilli, Paolo, Lachin, John M., Kolb, Hubert
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551636/
https://www.ncbi.nlm.nih.gov/pubmed/18628574
http://dx.doi.org/10.2337/dc07-2451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551636/
https://www.ncbi.nlm.nih.gov/pubmed/18628574
http://dx.doi.org/10.2337/dc07-2451

Ejemplares similares